2-Methyl-1,3-thiazole-4-carboximidamide hydrochloride
CAS: 18876-82-9
Ref. 3D-FM35793
| 1g | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Información del producto
- Buttpark 43\57-66
- 2-Methylthiazole-4-Carboxamidine Hydrochloride
- 2-Methyl-1,3-thiazole-4-carboximidamideHCL
2-Methyl-1,3-thiazole-4-carboximidamide hydrochloride (MTZ) is a medicine that is used to treat anemia caused by chronic kidney disease. It works by increasing the production of red blood cells in the bone marrow. In clinical trials, MTZ was found to be safe and effective for the treatment of anemia in patients with chronic kidney disease. The drug has been shown to be well tolerated by humans, and it can be given orally. The drug has also been shown to have hematological effects in humans, which may be due to its ability to activate hypoxia-inducible factor 1α and stimulate erythropoiesis through hydroxylases.
Propiedades químicas
Consulta técnica sobre: 3D-FM35793 2-Methyl-1,3-thiazole-4-carboximidamide hydrochloride
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
